Tell us about your organisation and its journey to date.
At BIORUS, we are committed to providing innovative, trusted, high-quality, and cost-effective solutions to the healthcare and life science sectors. Our journey began in 2007 when I visited a cancer center in Jordan and witnessed the struggles of cancer patients, their loved ones, and healthcare staff. This experience inspired me to create BIORUS in 2020 with the goal of transforming the healthcare industry. Our team leverages the pillars of reliability, trust, and loyalty to provide bespoke scientific solutions for the industry.
Since our company's inception, we have become a top healthcare solution distributor and earned a reputation as a reliable and trusted partner for healthcare and life science organizations around the UAE.
How has the organization evolved to address the challenges of an ever-changing healthcare sector? Please list some accomplishments
At BIORUS, we provide the most cutting-edge and innovative products to healthcare professionals around the world. Our aim is to bring the latest and greatest life science technologies to the market, with the ultimate goal of helping clinicians save more lives. We strive to make the operations of laboratories more efficient, and to educate clinicians about the new and upcoming technologies that can expedite patient results, providing faster and more effective treatments.
We work on women’s healthcare by having innovative STI solutions using biochip multiplex fully automated technology. We also provide solutions for fast phenotypic susceptibility which gives results within seven hours for critical sepsis patients. Moreover, we provide total turnkey vivarium solutions for research laboratories. We also have a high throughput microbioreactor that allows for the real-time evaluation of key cultivation parameters for both aerobes and anaerobes, making it a truly unique product in the GCC and UAE markets.
Additionally, we are proud to announce that we will soon be distributing automated NAT solutions that will help laboratories reduce learning curves and optimize workflow efficiency. Our commitment to bringing the most innovative products to the medical field is a testament to our dedication to improving patient care and outcomes.
Give us an insight into your portfolio and solutions targeted at the Middle East region.
BIORUS has been actively working to stay on top of the growing challenges in the healthcare sector by onboarding several new manufacturers that help the company to rapidly adapt to the fast-paced industry. BIORUS is thrilled to announce its newest venture into the blood banking industry with Grifols, a leader in NAT testing.
Moreover, with the ever-growing concern of antimicrobial resistance, it has become imperative to come up with new and improved solutions that will give us phenotypic antimicrobial susceptibility within the least time possible. With Accelerate Pheno, not only can you get ID within 90 minutes but you can get phenotypic susceptibility results all within seven hours. As the need for animal research increases, BIORUS is equipped with the best and complete vivarium solutions for your lab with Tecniplast. We also have BioLector XT Microbioreactor by Beckman Coulter Life Sciences for the real-time evaluation of key cultivation parameters of microbes.
BIORUS also focuses on healthcare for women by providing advanced STI solutions from Randox- Bosch that requires little to no hands-on, using biochip multiplex technology covering multiple parameters and giving results in as less as 120 minutes.
Tell us about your recent and upcoming investments and partnerships in this field.
At BIORUS, we strive to provide the best solutions to our clients, and to make sure they are feeling the added value of our services. In 2022 alone, we have conducted 24 evaluations to educate professionals and clinicians on the positive impact our solutions have on patient healthcare. In fact, one hospital has conducted the evaluation for one year as a proof of concept, to study the clinical impact on the patients in terms of reduction in unnecessary antimicrobial treatment and reduction in length of stay and is currently in the process of sharing its results in publications.
Our commitment to our clients is further illustrated by our recent strategic partnerships with Grifols, Randox, Vircell, and Microptic, which will let us offer complete solutions to laboratories across the United Arab Emirates. We believe that these partnerships will enable us to provide the best healthcare services to those in need.
What will you be showcasing at Medlab Middle East 2023?
BIORUS is excited to be a platinum sponsor at Medlab 2023 and is proud to showcase our technologies alongside our manufacturers: